University Of Virginia
Clinical trials sponsored by University Of Virginia, explained in plain language.
-
New combo therapy aims to slash sepsis deaths in HIV patients
Disease control Not yet recruitingThis study tests whether adding steroids and a powerful antibiotic combination to standard care can help more people with HIV survive sepsis, a life-threatening infection. The trial will enroll 344 adults in Africa who have sepsis that is not getting better. The goal is to find a…
Phase: PHASE3 • Sponsor: University of Virginia • Aim: Disease control
Last updated Apr 29, 2026 10:02 UTC
-
Immune cells armed with antibody enter trial for Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase study tests whether immune cells (white blood cells) coated with a special antibody can safely attack and shrink tumors in people with metastatic breast or prostate cancer that has stopped responding to standard treatments. About 23 participants will receive week…
Phase: PHASE1, PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC